Both gene and protein expressions of Kalirin were decreased in the hippocampus of Alzheimer's disease (AD) patients in a study, and the lowered Kalirin level may contribute to higher iNOS (inducible nitric oxide synthase) activity observed in the hippocampal specimens of the patients [53, 54]. Here, KALRN is linked to early-onset autosomal dominant Alzheimer disease.